Effect of beta-blockade on ascending aortic dilatation in children with the Marfan syndrome
- PMID: 17261408
- DOI: 10.1016/j.amjcard.2006.08.048
Effect of beta-blockade on ascending aortic dilatation in children with the Marfan syndrome
Abstract
Aortic root dilatation is the principal life-threatening complication in Marfan syndrome, leading to aortic regurgitation, dissection, and rupture. Beta blockade slows aortic dilatation in adults, but there has been no definitive evidence in children. Therefore, the evolution of aortic diameter at the level of the sinuses of Valsalva in 155 children (82 males, 73 females) aged <12 years who had been diagnosed with Marfan syndrome according to international criteria was retrospectively studied. Affected children treated by beta blockade >or=1 time during their lives (n = 77, mean age at diagnosis 6.1 +/- 3.2 years) were compared with affected children who had never received beta blockers (n = 78; 42 males, mean age 7.4 +/- 5.2 years). A mean delay of 1.3 years was observed between diagnosis and the initiation of beta blockade in the treated group (mean age at initiation 7.5 years). At the time of diagnosis, aortic diameters were similar in the 2 groups, but after 1.3 years, aortic diameters were greater in the group of children in whom beta blockers had been initiated. On univariate analysis, aortic diameter was related to age and height, but not gender or familial history of aortic dissection. On multivariate analysis, treatment and age remained significant determinants of aortic diameter. Beta blockade significantly decreased the rate of aortic dilatation at the level of the sinuses of Valsalva by a mean of 0.16 mm/year (p <0.05), an effect that increased with treatment duration. A trend toward lower cardiac mortality, decreased need for preventive aortic surgery, and less dissection was observed. In conclusion, beta blockade appears to limit aortic dilatation during childhood in patients affected by Marfan syndrome. Therefore, this treatment should be recommended as soon as the diagnosis is made.
Similar articles
-
Losartan added to β-blockade therapy for aortic root dilation in Marfan syndrome: a randomized, open-label pilot study.Mayo Clin Proc. 2013 Mar;88(3):271-6. doi: 10.1016/j.mayocp.2012.11.005. Epub 2013 Jan 12. Mayo Clin Proc. 2013. PMID: 23321647 Clinical Trial.
-
Beta-blocker therapy does not alter the rate of aortic root dilation in pediatric patients with Marfan syndrome.J Pediatr. 2007 Jan;150(1):77-82. doi: 10.1016/j.jpeds.2006.09.003. J Pediatr. 2007. PMID: 17188619
-
Determinants of rapid progression of aortic root dilatation and complications in Marfan syndrome.Int J Cardiol. 2006 Jan 13;106(2):177-82. doi: 10.1016/j.ijcard.2005.01.040. Int J Cardiol. 2006. PMID: 16321689
-
Role of angiotensin receptor blockers for management of aortic root dilation associated with Marfan syndrome.Expert Rev Cardiovasc Ther. 2011 Oct;9(10):1257-9. doi: 10.1586/erc.11.130. Expert Rev Cardiovasc Ther. 2011. PMID: 21985537 Review. No abstract available.
-
A systematic review of the pharmacological management of aortic root dilation in Marfan syndrome.Cardiol Young. 2013 Aug;23(4):568-81. doi: 10.1017/S1047951112001412. Epub 2012 Oct 19. Cardiol Young. 2013. PMID: 23083542 Review.
Cited by
-
Bicuspid aortic valve aortopathy: genetics, pathophysiology and medical therapy.Interact Cardiovasc Thorac Surg. 2013 Sep;17(3):554-9. doi: 10.1093/icvts/ivt196. Epub 2013 May 31. Interact Cardiovasc Thorac Surg. 2013. PMID: 23728086 Free PMC article. Review.
-
2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.Circulation. 2022 Dec 13;146(24):e334-e482. doi: 10.1161/CIR.0000000000001106. Epub 2022 Nov 2. Circulation. 2022. PMID: 36322642 Free PMC article.
-
Management of aortic disease in children with FBN1-related Marfan syndrome.Eur Heart J. 2024 Oct 14;45(39):4156-4169. doi: 10.1093/eurheartj/ehae526. Eur Heart J. 2024. PMID: 39250726 Free PMC article. Review.
-
A Case Based Approach to Clinical Genetics of Thoracic Aortic Aneurysm/Dissection.Biomed Res Int. 2016;2016:9579654. doi: 10.1155/2016/9579654. Epub 2016 May 25. Biomed Res Int. 2016. PMID: 27314043 Free PMC article. Review.
-
The Genetics of Aortopathies in Clinical Cardiology.Clin Med Insights Cardiol. 2017 May 30;11:1179546817709787. doi: 10.1177/1179546817709787. eCollection 2017. Clin Med Insights Cardiol. 2017. PMID: 28607545 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical